rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1987-11-5
|
pubmed:abstractText |
To determine the role of activated protein kinase C in vascular smooth muscle contraction, phorbol dibutyrate was used to stimulate this enzyme in order to evaluate the source(s) of Ca++ (10(-8) to 3 X 10(-6) M) elicited a concentration-dependent sustained contraction which was slow in onset but progressive in developed tension. The maximal contractile response induced by phorbol dibutyrate was only partly dependent on influx of extracellular Ca++ as shown by similar reductions (40%) produced by Ca++-free buffer, LaCl3 (1 mM) or nifedipine (10(-6) M). These data suggest that phorbol dibutyrate is able to open Ca++ channels which are sensitive to nifedipine blockade. However, unlike norepinephrine or K+-depolarization, phorbol dibutyrate evoked a slow 45Ca++ influx which occurred only after extended contact time. Pretreatment with nifedipine again abolished this response. In contrast to norepinephrine, phorbol dibutyrate did not cause 45Ca++ efflux indicating that intracellular Ca++ was not mobilized. It is concluded that the residual 60% contraction to phorbol dibutyrate most likely occurs via a mechanism independent of the Ca-calmodulin pathway.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Lanthanum,
http://linkedlifedata.com/resource/pubmed/chemical/Nifedipine,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Phorbol 12,13-Dibutyrate,
http://linkedlifedata.com/resource/pubmed/chemical/Phorbol Esters,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 4,5-Diphosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositols,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/lanthanum chloride
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-3565
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
242
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
934-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2821231-Animals,
pubmed-meshheading:2821231-Aorta,
pubmed-meshheading:2821231-Calcium,
pubmed-meshheading:2821231-Lanthanum,
pubmed-meshheading:2821231-Male,
pubmed-meshheading:2821231-Nifedipine,
pubmed-meshheading:2821231-Norepinephrine,
pubmed-meshheading:2821231-Phorbol 12,13-Dibutyrate,
pubmed-meshheading:2821231-Phorbol Esters,
pubmed-meshheading:2821231-Phosphatidylinositol 4,5-Diphosphate,
pubmed-meshheading:2821231-Phosphatidylinositols,
pubmed-meshheading:2821231-Protein Kinase C,
pubmed-meshheading:2821231-Rats,
pubmed-meshheading:2821231-Rats, Inbred Strains,
pubmed-meshheading:2821231-Vasoconstriction
|
pubmed:year |
1987
|
pubmed:articleTitle |
Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate.
|
pubmed:affiliation |
E. I. du Pont de Nemours and Company, Inc., Medical Products Department, Wilmington, Delaware.
|
pubmed:publicationType |
Journal Article,
In Vitro
|